Concurrent Investment Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Concurrent Investment Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,000	Closed	-$3.7K	–	2195
2026 Q1	$3.7K	Hold	15,000	–	–	﹤0.01%	1928
2025 Q4	$6.3K	Hold	15,000	–	–	﹤0.01%	1774
2025 Q3	$10.1K	Hold	15,000	–	–	﹤0.01%	1481
2025 Q2	$8.12K	Hold	15,000	–	–	﹤0.01%	1397
2025 Q1	$9.84K	Buy	+15,000	New	+$15.9K	﹤0.01%	1228

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Concurrent Investment Advisors's SGMO Position: Q2 2026 in Review

Concurrent Investment Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 15,000 shares — an estimated $3.7K sold.

Concurrent Investment Advisors first reported a position in SGMO in Q1 2025 and held it in 5 quarters. The position peaked at $10.1K in Q3 2025. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Concurrent Investment Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Concurrent Investment Advisors sold 15,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $3.7K.
Concurrent Investment Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q1 2025 and held it in 5 quarters.
Concurrent Investment Advisors's SANGAMO THERAPEUTICS INC position peaked at $10.1K in Q3 2025.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.